BACE1 and Alzheimer disease: A crucial characteristic of AD is an aberrant accumulation of β-amyloid (Aβ) peptides in the brain, in terms of enhanced cleavage of Aβ precursor protein (APP) by the rate-limiting β-site APP-cleaving enzyme 1 (BACE1) (Shi et al., 2017).